about
Echocardiographic findings associated with mortality ortransplant in patients with pulmonary arterial hypertension:A systematic review and meta-analysisEvaluating the systemic right ventricle by CMR: the importance of consistent and reproducible delineation of the cavity.New predictors of mortality in adults with congenital heart disease and pulmonary hypertension: Midterm outcome of a prospective study.Development of an Online, Evidence-Based Patient Information Portal for Congenital Heart Disease: A Pilot StudyTBX4 mutations (small patella syndrome) are associated with childhood-onset pulmonary arterial hypertensionPregnancy and delivery in women after Fontan palliationEffects of High-Intensity Interval Training versus Continuous Training on Physical Fitness, Cardiovascular Function and Quality of Life in Heart Failure Patients.Automated Assessment of Right Ventricular Volumes and Function Using Three-Dimensional Transesophageal Echocardiography.Psychosocial impact of implantable cardioverter defibrillators (ICD) in young adults with Tetralogy of Fallot.Treatment of pulmonary arterial hypertension in congenital heart disease in Singapore versus the Netherlands: age exceeds ethnicity in influencing clinical outcomeThe effect of an advanced glycation end-product crosslink breaker and exercise training on vascular function in older individuals: a randomized factorial design trial.Regional ventricular performance and exercise training in children and young adults after repair of tetralogy of Fallot: randomized controlled pilot study.Effect of valsartan on systemic right ventricular function: a double-blind, randomized, placebo-controlled pilot trial.Exercise training improves exercise capacity in adult patients with a systemic right ventricle: a randomized clinical trial.Aneurysm of the Pulmonary Artery, a Systematic Review and Critical Analysis of Current Literature.Value of Cardiovascular Magnetic Resonance Imaging in Noninvasive Risk Stratification in Tetralogy of Fallot.Contemporary survival of adults with congenital heart disease.Cardiovascular disease risk is only elevated in hypertensive, formerly preeclamptic women.The value of 18F-FDG PET/CT in diagnosing infectious endocarditis.Decrease in quality of life predicts mortality in adult patients with pulmonary arterial hypertension due to congenital heart disease.Impact of prolonged walking exercise on cardiac structure and function in cardiac patients versus healthy controls.Right vEntricular Dysfunction in tEtralogy of Fallot: INhibition of the rEnin-angiotensin-aldosterone system (REDEFINE) trial: Rationale and design of a randomized, double-blind, placebo-controlled clinical trial.Metastatic infectious disease and clinical outcome in Staphylococcus aureus and Streptococcus species bacteremia.QRS fragmentation is superior to QRS duration in predicting mortality in adults with tetralogy of Fallot.Prevalence of asymptomatic heart failure in formerly pre-eclamptic women: a cohort study.Individualised prediction of pulmonary homograft durability in tetralogy of Fallot.The role of cystatin C as a biomarker for prognosis in pulmonary arterial hypertension due to congenital heart disease.Aortic valve prosthesis-patient mismatch and exercise capacity in adult patients with congenital heart disease.Severe tricuspid regurgitation is predictive for adverse events in tetralogy of Fallot.Low Plasma Volume in Normotensive Formerly Preeclamptic Women Predisposes to Hypertension.Bosentan in pulmonary arterial hypertension: a comparison between congenital heart disease and chronic pulmonary embolism.Down patients with Eisenmenger syndrome: is bosentan treatment an option?Rationale and design of a trial on the effect of angiotensin II receptor blockers on the function of the systemic right ventricle.18F-FDG PET/CT for detection of metastatic infection in gram-positive bacteremia.Atherosclerosis in patients with cyanotic congenital heart disease.Mortality in adult congenital heart disease.Pregnancy in women with corrected tetralogy of Fallot: occurrence and predictors of adverse events.Lifetime Risk of Pulmonary Hypertension for All Patients After Shunt Closure.Gender and outcome in adult congenital heart disease.Ascending aorta dilatation in patients with bicuspid aortic valve stenosis: a prospective CMR study.
P50
Q26748865-47E559D4-1619-4944-93AF-ECEAA3AEEC1FQ30483466-50F78AF2-1DCF-4239-8C76-2FC3320612D3Q33165104-29D2C31B-93B9-4636-8DFA-7CA15D4986B2Q33619577-98EC3F4F-53AE-4B02-9D1D-1C349A7C2F1DQ34339756-FD467436-2A39-4151-8D27-0BF516D1EE10Q35772312-D82FFED6-8D1F-4061-B1BC-E50D5F30F99CQ35827511-44959EFF-5E17-4369-B0BB-2049815DB464Q35860095-2C7F2B33-1400-4D08-9B8B-E573246CD2D8Q36041210-F0C0539F-866F-4D5C-8E39-88D196A6094CQ36951990-3C56653B-6ACF-4702-9902-5C66B93977A5Q37603478-4539C8D0-8EF0-41CE-9B8C-096DD1D04B56Q38414738-B81FEEC0-9485-427D-92EE-544E249EA8D6Q38459499-5B29D0C0-3CEC-454B-B1F2-64F8FD74E625Q38481959-9FF5624E-5F31-4632-A9EA-7FBA1458D829Q38629665-75EFB098-F44C-4994-ACCA-AB39DDA08051Q38939592-6333460A-2E32-4A0E-A9EF-B9CD008CDBCCQ38945868-63EBAB36-A88B-46FC-8D6E-A2792D2AA2A7Q39142729-DEBBC581-8406-4C84-8836-E90D3DEA889DQ39455252-CE0EDDEA-4EB2-46D3-B1EE-7907FA539FCCQ39952972-9325CA13-394F-44C7-BA3A-C42001767604Q40012261-EE4892C9-AAA6-4A15-9E64-47BCDFD7B690Q40222560-E513D497-D1F9-40E2-BDFE-90E34B1D2747Q40294131-1BF3091E-364E-44D9-957A-E630B42431F5Q40497847-6C757E0C-6ACF-4302-9B97-731164493777Q40655618-02A963C1-0A3D-426F-9F80-779FC7CA65C5Q40735878-C70EF570-D787-432C-A1B0-9F0DBDF581D3Q40898258-9255196F-52B2-47D7-82CE-BB75F83AC49BQ41104901-E12006D0-E94F-47A9-8F76-C8ED6FD48B6EQ41132301-F9075802-3B3B-4A40-896F-8BBEFBC1247CQ41359552-349C3D19-B4F9-434A-A951-9884E1224363Q42284467-2C148470-EFB4-4941-B822-F390610A0591Q42660332-C035110F-6FED-42A0-B4A3-F50DD2316D80Q42795432-1BAEE9FD-2C74-4BC7-B0D3-558E96B1BF06Q42957426-05EE0F33-A9B2-4B10-A3F8-D4D6C1ED84B2Q43043736-8D9835CC-4F81-49FD-B35D-EBC811EA4CFDQ43140645-D078BCB7-6774-43F7-81EE-75FE7736BC0DQ43988222-EBAA9D77-E3A3-4078-9F57-0F85489F150FQ44280927-699EB6A8-DCA5-46B8-AE39-A856A6DC4A18Q44529052-49EAA176-17B9-4AAB-B2F7-DD83071BD0F2Q44554513-A6616043-39F5-4C31-BFB6-7A5E8BE39656
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-7843-8251
@en
name
Arie P van Dijk
@ast
Arie P van Dijk
@en
Arie P van Dijk
@nl
type
label
Arie P van Dijk
@ast
Arie P van Dijk
@en
Arie P van Dijk
@nl
prefLabel
Arie P van Dijk
@ast
Arie P van Dijk
@en
Arie P van Dijk
@nl
P106
P31
P496
0000-0002-7843-8251